Abbott Laboratories Revenue 2006-2020 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending March 31, 2020 was $7.726B, a 2.53% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending March 31, 2020 was $32.095B, a 4.47% increase year-over-year.
  • Abbott Laboratories annual revenue for 2019 was $31.904B, a 4.34% increase from 2018.
  • Abbott Laboratories annual revenue for 2018 was $30.578B, a 11.64% increase from 2017.
  • Abbott Laboratories annual revenue for 2017 was $27.39B, a 31.35% increase from 2016.
Abbott Laboratories Annual Revenue
(Millions of US $)
2019 $31,904
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
2008 $29,528
2007 $25,914
2006 $22,476
2005 $22,338
Abbott Laboratories Quarterly Revenue
(Millions of US $)
2020-03-31 $7,726
2019-12-31 $8,314
2019-09-30 $8,076
2019-06-30 $7,979
2019-03-31 $7,535
2018-12-31 $7,765
2018-09-30 $7,656
2018-06-30 $7,767
2018-03-31 $7,390
2017-12-31 $7,589
2017-09-30 $6,829
2017-06-30 $6,637
2017-03-31 $6,335
2016-12-31 $5,333
2016-09-30 $5,302
2016-06-30 $5,333
2016-03-31 $4,885
2015-12-31 $5,188
2015-09-30 $5,150
2015-06-30 $5,170
2015-03-31 $4,897
2014-12-31 $5,356
2014-09-30 $5,079
2014-06-30 $5,057
2014-03-31 $4,755
2013-12-31 $4,008
2013-09-30 $4,825
2013-06-30 $5,446
2013-03-31 $5,378
2012-12-31 $3,188
2012-09-30 $5,265
2012-06-30 $5,313
2012-03-31 $5,284
2011-12-31 $10,377
2011-09-30 $9,817
2011-06-30 $9,616
2011-03-31 $9,041
2010-12-31 $9,968
2010-09-30 $8,675
2010-06-30 $8,826
2010-03-31 $7,698
2009-12-31 $8,790
2009-09-30 $7,761
2009-06-30 $7,495
2009-03-31 $6,718
2008-12-31 $7,950
2008-09-30 $7,498
2008-06-30 $7,314
2008-03-31 $6,766
2007-12-31 $7,221
2007-09-30 $6,377
2007-06-30 $6,371
2007-03-31 $5,946
2006-12-31 $6,821
2006-09-30 $5,574
2006-06-30 $5,501
2006-03-31 $4,580
2005-12-31 $6,047
2005-09-30 $5,384
2005-06-30 $5,524
2005-03-31 $5,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $161.726B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.997B 19.98
Stryker (SYK) United States $67.540B 21.92
Boston Scientific (BSX) United States $49.131B 23.10
Baxter (BAX) United States $43.670B 26.66
Lonza Group Ag (LZAGY) Switzerland $39.461B 0.00
Terumo (TRUMY) Japan $28.983B 37.05
EssilorLuxottica Societe Anonyme (ESLOY) France $28.175B 0.00
ResMed (RMD) United States $27.776B 43.84
Zimmer Biomet Holdings (ZBH) United States $24.636B 15.50
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.688B 0.00
Bio-Rad Laboratories (BIO) United States $13.385B 60.93
Insulet (PODD) United States $12.255B 1214.13
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.397B 73.84
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.534B 13.48
Hill-Rom Holdings (HRC) United States $7.306B 20.60
GN STORE NORD (GNNDY) Denmark $6.972B 36.02
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.669B 0.00
Haemonetics (HAE) United States $4.505B 27.06
Neogen (NEOG) United States $4.090B 69.29
ICU Medical (ICUI) United States $3.840B 28.01
GW Pharmaceuticals (GWPH) United Kingdom $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.684B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.679B 0.00
Envista Holdings (NVST) United States $3.358B 0.00
NuVasive (NUVA) United States $2.852B 22.91
National Vision Holdings (EYE) United States $2.450B 42.39
TG Therapeutics (TGTX) United States $2.146B 0.00
AtriCure (ATRC) United States $1.801B 0.00
Aurora Cannabis (ACB) Canada $1.407B 0.00
MacroGenics (MGNX) United States $1.372B 0.00
Aphria (APHA) Canada $1.228B 0.00
Cardiovascular Systems (CSII) United States $1.113B 0.00
NanoString Technologies (NSTG) United States $1.107B 0.00
Cerus (CERS) United States $1.082B 0.00
Phibro Animal Health (PAHC) United States $1.063B 21.18
Meridian Bioscience (VIVO) United States $0.998B 37.56
PetIQ (PETQ) United States $0.989B 28.56
InMode (INMD) Israel $0.905B 19.14
Vapotherm (VAPO) United States $0.873B 0.00
Zynex (ZYXI) United States $0.826B 82.90
Omeros (OMER) United States $0.802B 0.00
Quanterix (QTRX) United States $0.775B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.744B 123.85
OraSure Technologies (OSUR) United States $0.722B 145.38
Eagle Pharmaceuticals (EGRX) United States $0.657B 47.04
VAREX IMAGING (VREX) United States $0.592B 14.71
Surmodics (SRDX) United States $0.588B 70.89
Lantheus Holdings (LNTH) United States $0.569B 11.44
LeMaitre Vascular (LMAT) United States $0.533B 30.34
Owens & Minor (OMI) United States $0.480B 12.70
BioLife Solutions (BLFS) United States $0.425B 148.64
Viemed Healthcare (VMD) United States $0.373B 33.10
Repro-Med Systems (KRMD) United States $0.362B 299.33
Cytosorbents (CTSO) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.323B 23.44
HEXO (HEXO) $0.318B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.297B 0.00
Organigram Holdings (OGI) Canada $0.274B 0.00
InfuSystems Holdings (INFU) United States $0.232B 128.22
Female Health (VERU) United States $0.227B 0.00
Chimerix (CMRX) United States $0.192B 0.00
Bovie Medical (APYX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.186B 0.00
Evolus (EOLS) United States $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
Fonar (FONR) United States $0.138B 12.21
Rockwell Medical (RMTI) United States $0.135B 0.00
United Health Products (UEEC) United States $0.130B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
MTech Acquisition (KERN) United States $0.117B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.076B 0.00
United-Guardian (UG) United States $0.068B 15.76
Capricor Therapeutics (CAPR) United States $0.066B 0.00
Chembio Diagnostics (CEMI) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.052B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.034B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00